Thomas Moulton

Bayer (United States) — United States

Medicine · Health Sciences

17h-index2.0kcitations47works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(11), Iron Metabolism and Disorders(7), Hemoglobinopathies and Related Disorders(6), Epigenetics and DNA Methylation(4), Monoclonal and Polyclonal Antibodies Research(4)

Publications47 total

Effectiveness of Octocog Alfa ( <scp>BAY</scp> 81‐8973) to Treat People With Haemophilia A Enrolled in the <scp>ATHNdataset</scp> , Including Under‐Represented Subgroups
European Journal Of Haematology·2025Open Access
Effectiveness of Damoctocog Alfa Pegol to Treat Patients With Hemophilia A Enrolled in the <scp>ATHNdataset</scp>
European Journal Of Haematology·2024Open Access
Real-World Data on Hemophilia a Patients Transitioning from Bay 81-8973 to Bay 94-9027 and from Bay 14-2222 to Bay 81-8973 and then to Bay 94-9027 in the Athndataset
Blood·2023Open Access
PB1291 Joint Range of Motion Findings Among Female Patients with Hemophilia A from the ATHNdataset
Research and Practice in Thrombosis and Haemostasis·2023· 1 citedOpen Access
PB1278 Real-World Data on Hemophilia A Patients with Inhibitors Switching to Either BAY 94-9027 or BAY 81-8973 in the ATHNdataset
Research and Practice in Thrombosis and Haemostasis·2023Open Access
PB0672 Real-World Data on Hemophilia A Patients Switching to Either BAY 94-9027 or BAY 81-8973 from Emicizumab Using the ATHNdataset
Research and Practice in Thrombosis and Haemostasis·2023Open Access
Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials
Journal of Blood Medicine·2023Open Access
Real-World Use of Octocog Alfa and Damoctocog Alfa Pegol in Women with Hemophilia a from the ATHNdataset
Blood·2022· 1 cited
Real-World Effectiveness of Damoctocog Alfa Pegol in the Subgroup of Adolescent Hemophilia A Patients Aged 12-18 Years in the ATHNdataset
Blood·2021
Dynamic of lipoprotein responses in patients with severe COVID-19
Atherosclerosis·2021Open Access
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease
JAMA·2021· 41 citedOpen Access
Improvement of Efficacy Outcomes in Patients Who Switched from Sucrose-Formulated rFVIII to BAY 81-8973 Prophylaxis in the LEOPOLD Clinical Trials
Blood·2020
Improved Bleeding Outcomes in Patients Who Switched From Sucrose-Formulated rFVIII to BAY 94-9027 Prophylaxis in PROTECT VIII
Blood·2020
Is type 3c diabetes the ‘middle child' of diabetes groups? Under appreciated, complicated and ignored.
HPB·2020Open Access
Comparison of two clinical motor scales in individuals with giant axonal neuropathy (GAN)
Neuromuscular Disorders·2015· 1 cited
Vitamin D Level and Its Correlation With Hemoglobin In Pediatric Sickle Cell Disease Patients
Blood·2013· 6 cited
A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients
Blood·2013
A Novel β Globin Gene Mutation, Reported As An α Chain Hemoglobin Variant By High Performance Liquid Chromatography (HPLC) &amp; As Sickle Cell Trait On New Born Screening: A case Report
Blood·2013
Severe Vitamin D Deficiency in a Patient With Sickle Cell Disease
Journal of Pediatric Hematology/Oncology·2013· 6 cited
Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: Novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia
The Journal of Pediatrics·2011· 76 cited
page 1 of 3Next →

Frequent Co-authors

Michael Recht(8), Benjamin Tycko(6), Jessica Charlet(6), Martin Chandler(5), Ludovico Guarini(4), Soldano Ferrone(4), Lena Charafi(4), Yue Hao(3), Taria Crenshaw(3), Terrence Hensle(3), Joseph H. Graziano(3), Nancy J. Lolacono(3), Luwa Yuan(3), Paul B. Fisher(3), Jennifer Busse(3), Kranthi Nandan Seelaboyina(3), Kaan Boztuǧ(2), Philip S. Rosenberg(2), Julie Curtin(2), Nima Rezaei(2)